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Background: COPD is among the leading causes of chronic morbidity and mortality in the 
European Union with an estimated annual economic burden of €25.1 billion. Various care pathways 
for COPD exist across Europe leading to different responses to similar problems. Determining 
these differences and the similarities may improve health and the functioning of health services.
Objective: The aim of this study was to compare COPD patients’ care pathway in five European 
Union countries including England, Ireland, the Netherlands, Greece, and Germany and to 
explore health care professionals’ (HCPs) perceptions about the current pathways.
Methods: HCPs were interviewed in two stages using a qualitative, semistructured email 
interview and a face-to-face semistructured interview.
Results: Lack of communication among different health care providers managing COPD and 
comorbidities was a common feature of the studied care pathways. General practitioners/family 
doctors are responsible for liaising between different teams/services, except in Greece where 
this is done through pulmonologists. Ireland and the UK are the only countries with services for 
patients at home to shorten unnecessary hospital stay. HCPs emphasized lack of communication, 
limited resources, and poor patient engagement as issues in the current pathways. Furthermore, 
no specified role exists for pharmacists and informal carers.
Conclusion: Service and professional integration between care settings using a unified system 
targeting COPD and comorbidities is a priority. Better communication between health care 
providers, establishing a clear role for informal carers, and enhancing patients’ engagement 
could optimize current care pathways resulting in a better integrated system.
Keywords: COPD, comorbidities, care delivery pathway, comparative analysis
Introduction
COPD is a common preventable and treatable pulmonary disease with symptoms 
of dyspnea, cough, and sputum production.1 COPD is among the leading causes of 
chronic morbidity and mortality in the European Union (EU) with ~300,000 people 
with the condition dying each year.2 The prevalence of COPD has been increasing with 
different ratios nationally and even regionally.3,4 Table 1 summarizes COPD statistics 
in Germany, Greece, Ireland, the Netherlands, and the UK.5–8
The estimated annual economic burden of COPD in Europe, in terms of direct 
(health care) and indirect (lost production) costs, is €25.1 billion.4 In addition, acute 
exacerbations increase health care use, accelerate decline in lung function, and reduce 
patients’ quality of life (QoL).1
Chronic diseases often develop together, and comorbidities markedly affect 
health outcomes in COPD.9 In fact, patients with COPD mainly die of nonrespiratory 
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diseases,10 such as cardiovascular diseases (~25%), cancers 
(mainly lung cancer, 20%–33%), and other causes (30%). 
COPD is a frequent concomitant disease in patients with heart 
failure, and chronic heart failure is seen in $20% of primary 
care patients with stable COPD.9 Diabetes mellitus also 
affects 1.6%–16% of people with COPD, with prevalence 
increasing as lung function deteriorates. This prevalence 
has been found to be higher than in non-COPD patients.10,11 
In addition, several studies have demonstrated that anxiety 
and depression are prevalent in COPD patients and lead to 
poorer disease-related outcomes and more frequent acute 
exacerbations and hospitalizations.12,13
The complex nature of COPD and its comorbidities 
requires integrated coordinated approaches, including a mul-
tidisciplinary team and explicit involvement of patients.14,15 
Several studies have shown that integrated COPD care can 
reduce hospital admission and readmission rates, length 
of hospital stay, emergency department visits, mortality, 
disease costs, and overall fragmented care.16–23 Moreover, 
integrated care can reduce COPD patients’ anxiety and 
depression and improve their health-related QoL and 
satisfaction.19,20,22 This could potentially be attributed to the 
fact that integrated care improves disease knowledge, self-
management, early detection and treatment of exacerbations, 
and treatment adherence.19,22–24
Countries in Europe are implementing a range of 
approaches to better manage chronic diseases, meet the 
needs of patients, and facilitate sharing of experiences, thus 
enabling cross-country learning.14,15 However, countries often 
have different care pathways for long-term conditions and 
thus respond in different ways to similar problems.25 Even 
though these health systems differ widely in care settings, 
professional roles, and coordination mechanisms, there is 
an opportunity for these systems to learn from each other.14 
Determining similarities and differences, using comparative 
research, can improve health and the functioning of health 
services.26 In addition, using health care professionals’ 
(HCPs) experience and perception could be beneficial 
as it increases the chances of adapting any solutions or 
interventions during implementation.
In this study, the care pathway for patients with COPD 
was compared across five countries: England, Ireland, the 
Netherlands, Greece, and Germany. The purpose was to 
explore the similarities and differences in the care pathways 
and the services provided to patients, in addition to exploring 
HCPs’ perceptions about the current pathways.
Methods
This was a two-phase study conducted as a part of the 
WELCOME project (http://www.welcome-project.eu).27 
It mapped the current COPD patients’ care pathways as a first 
stage and then explored HCPs’ perceptions as a second stage.
Mapping care pathway
A qualitative study consisting of a semistructured two-stage 
email interview was undertaken to answer the research 
questions. The interview consisted of open-ended questions 
exploring COPD care pathway in each country. This included 
five topics: an overview of COPD management and guide-
lines employed, relationships with other HCPs and teams, 
support available for patients at home, available community 
and secondary care, and patients’ adherence to medication 
and lifestyle advice. Five COPD-specialized HCPs repre-
senting all clinical partners in the WELCOME project were 
invited to participate in the study. Once written informed 
consent to participate was received by email, the first stage 
interview schedule was sent to the participant. No ethical 
approval was deemed necessary for the first stage (mapping 
care pathway) by all clinical partners (refer to Data collection 
section for list of clinical partners).
hCPs’ perceptions
A qualitative study consisting of face-to-face semistructured 
interviews was used to elicit HCPs’ perceptions on the current 
COPD patient care pathway in the corresponding country. 
The interview consisted of open-ended questions exploring 
HCPs’ views on the current care pathway, their day-to-day 
Table 1 COPD statistics in five European Union countries
Country Total 
expenditures 
(US$/capita)a
COPD 
prevalence (%)
Hospital 
admission 
per 100,000b
COPD 
deaths  
per 100,000b
germany 3,764 13.27 261.7 17.55
greece 2,190 – – 11.61
Ireland 3,026 9.88 263.5 27.87
the netherlands 4,160 13.24 134.2 22.62
UK 2,899 12.44 155.58 25.89
Notes: “–”, no data. aData from OECD. Health expenditure and financing. OECD statistics-health. 2015. Available from: http://stats.oecd.org/Index.aspx?DatasetCode=sha.5 
bData from european respiratory society.6
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work, barriers and challenges in caring for COPD patients, 
and the support of other HCPs. The interview was developed 
in English. The final version was translated from English into 
two languages: Greek and Dutch.
Data collection
Data collection was carried out between March and 
June 2014. The HCPs’ face-to-face discussion during the 
interviews was led by a moderator, and the resulting con-
versation between the moderator and participants was audio 
recorded. A convenience and purposive sampling tech-
nique was used, with WELCOME project clinical partners 
identifying HCPs whom they believed to be particularly 
experienced with COPD care management. Clinical partners 
in each country approached potential participants to consider 
taking part in the study. Once permission was obtained, 
participants were contacted by the researchers, and written 
informed consent was obtained. This study was approved 
by the following clinical partners: Beaumont Hospital 
Ethics (Medical Research) Committee (Dublin, Ireland), 
Scientific Board of the G. Papanikolaou General Hospital 
(Thessaloniki, Greece), Medical Research Ethics Commit-
tees United (Nieuwegein, the Netherlands), Croydon Health 
Services NHS Trust Information Governance (London, UK) 
and University Medical Centre Schleswig-Holstein (Kiel, 
Germany).
Data analysis
England and Greek recordings were sent to a third-party 
transcription service, and Irish and Dutch recordings 
were transcribed by the research team. The Greek and Dutch 
transcripts were translated into English by a third-party 
translation service.
Thematic content analysis was carried out using a struc-
tured approach for generating category systems. Burnard et al 
methodology28,29 is considered a systematic methodology 
for recording themes from semistructured interviews that 
use open-ended questions. Two researchers carried out 
the data analysis in various stages to reduce the possibil-
ity of any researcher bias during the theme development. 
Themes were confirmed and verified by detailed line-by-line 
reading of the transcripts, with the process being repeated 
to identify further themes. The next stage involved making 
a list of all the themes and eliminating those that had been 
duplicated. The data were then inspected for any overlapping 
or similar themes, which were further refined and reduced 
until a final list of themes was formulated and approved by 
both researchers.
Results
Care pathway mapping
Figure 1 illustrates the current COPD care pathways in the 
five countries. The pathway for COPD patients starts with 
the general practitioner (GP) in England, the Netherlands, 
and Germany, while in Greece and Ireland, it starts at the 
hospital (or secondary care).
The values of diagnostic parameters, normal ranges, 
therapeutic targets, and alerts for COPD patients are slightly 
different between the five countries. England and Ireland 
follow the National Institute for Health and Care Excellence 
COPD guidelines, the Netherlands follows the American 
Thoracic Society/European Respiratory Society guidelines, 
Greece follows the Global initiative for chronic obstructive 
lung disease guidelines, and Germany follows the National 
Guidelines for the Diagnosis and Therapy of COPD issued 
by “Deutsche Atemwegsliga” and “Deutsche Gesellschaft 
für Pneumologie und Beatmungsmedizin”.
The follow-up care services differ largely between 
countries. In England, the follow-up is provided by GP 
visits, community services, hospital chest clinics, and special 
clinical teams. The follow-up care services involve GPs, 
consultants, physiotherapists, and nurses. The special clinical 
teams, which operate through local respiratory teams, are 
hospital based but provide services in the community. In 
addition, England is the only country to provide community 
services. This includes the respiratory teams and community 
matrons providing specialist input and basic support includ-
ing respiratory team clinics, pulmonary rehabilitation (PR), 
and smoking cessation.
In Ireland, an outreach team consisting of a respiratory 
consultant, a practice physiotherapist, and nurses provide 
an early supported discharge, assisted discharge, PR, and 
transitional care program for inpatients. For outpatients, 
a service in a respiratory COPD clinic and a PR program 
are available.
In the Netherlands, the follow-up of patients takes place 
in primary or secondary care. GPs are involved in the preven-
tion, diagnosis and treatment, and follow-up care of COPD 
patients, and they have a gate-keeping role. The gate-keeping 
principle determines what hospital care and specialist care 
(except emergency care) are needed.
Specialist care involves referral to centers such as CIRO 
(Centre of Expertise for Chronic Organ Failure) where services 
such as PR get provided. In Greece, there are no special ser-
vices provided for outpatients with no role of primary care.
The follow-up parameters are similar and include 
spirometry-derived pulmonary function measures, body mass 
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index, blood gases, and oxygen saturation. The frequency of 
the follow-up depends on patients’ needs, but in general, it 
is performed in face-to-face clinics annually in England and 
biannually in Greece and Ireland.
England and Ireland are the only two countries that cur-
rently have special schemes to support patients at home. In 
England, a telehealth service is being provided to COPD 
patients in some districts along with facilitated discharge, 
management plans for some patients, and rescue packs. In 
Ireland, several programs are used to support patients at home, 
but only if the patients meet the inclusion criteria. This includes 
early supported and assisted discharge, which are interventions 
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Figure 1 COPD care pathways in five EU countries.
Abbreviations: DI, diabetologists; Ca, cardiologists; Ps, psychiatrists; rT, respiratory team; CC, chest clinic; Pr, pulmonary rehabilitation; sC, smoking cessation.
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aiming to accelerate discharge from hospital and providing 
support in a community setting.30 Another service is the transi-
tional care program consisting of actions designed to ensure the 
coordination and continuity of health care as patients transfer 
between different locations or different levels of care.31
Comorbidities
The management of COPD with comorbidities (namely, 
diabetes, heart failure, and mental conditions) was also com-
pared. In the five countries, the same management of COPD 
is followed even if the patient is diagnosed with comorbidi-
ties. Each of the comorbidities is managed independently 
following its own national guidelines and through separate 
clinical teams. It is noticeable that the different diagnosed 
condition services do not communicate with each other 
directly. In all countries, the GP is mainly responsible for 
liaising and referring patients between these services and 
clinical teams, except for Greece where this is done through 
the pulmonologists.
adherence and nonpharmacological interventions
The services being provided for lifestyle management are 
similar between the five countries. Smoking cessation, advice 
on annual flu vaccination, advice on importance of PR, and 
referral to a dietician are example of such services.
The patients’ adherence to therapy is monitored differently 
across the five EU countries. In Greece, the pulmonologists 
monitor adherence with questionnaires and device demon-
stration. In England, adherence and nonpharmacological 
interventions are monitored mainly by the appropriate teams 
(eg, PR and smoking cessation). In the Netherlands, the 
patients’ adherence is assessed during group sessions (train-
ing, education, smoking cessation). No specific services are 
available in Ireland to monitor adherence to therapy.
Based on our HCPs’ interviews, it was noticeable that the 
role of pharmacists in these countries is seen as limited, and 
there is no specified role or training for the informal carers 
(partners, family, and friends).
hCPs’ perceptions
Overall, 23 HCPs were interviewed as shown in Table 2. 
HCPs reported several issues regarding their view of the cur-
rent state of care including lack of communication, limited 
resources, and poor patient engagement.
lack of communication
It was evident that there is limited communication between 
HCPs and that there are challenges in communication 
between the health care teams in primary and secondary 
care. Fragmentation of communication between HCPs was 
highlighted by HCPs; in particular, continuity of care and 
knowing what happens to patients on a day-to-day basis were 
described as challenges in their work. In addition, HCPs 
highlighted the limited involvement of pharmacists in COPD 
patients care pathways.
Communication with other professionals is a challenge.
Different people involved in the care. So it’s very com-
plex in terms of […] the system is very complex.
limited resources and information
Lack of resources in terms of staff, time constraints, and 
training was voiced as a concern impacting quality of care 
especially in light of high admission rates with COPD 
patients. In addition, lack of resources available for patients 
to contact doctors when they feel sick and knowing how 
patients’ social and economic environment influences their 
physical condition were also reported as challenges.
A reduction in access to training really and to up-skilling 
our staff.
They [patients] will go in with a sort of shopping list 
and I, in theory have 10 minutes to get through it. So it’s 
sort of prioritizing and seeing if I can re-assign appointments 
when necessary and if it’s necessary.
Lack of sort of specialism or specialist’s support for 
the work that we’re delivering.
[…] post discharge, we’re meant to somehow follow all 
these patients up with the primary diagnosis of heart failure 
within two months. It’s often not possible.
Poor patient engagement
HCPs reported poor engagement by patients in their care, 
and they were not sure how to encourage patients to better 
manage their medication and treatment of COPD. This is 
particularly an issue in light of the complications from com-
plex treatment regimens.
Steroid treatments causing hyperglycemia in patients 
with COPD, patients’ lack of compliance with multiple 
Table 2 sample characteristics of interviewed hCPs’
Characteristics England Greece the Netherlands Ireland
gPs 1
specialist doctors 
(cardiologists, 
pulmonologists, 
diabetologists)
3 4 3 3
nurses 3 2 1
Physiotherapists 1 1 1
Total 8 4 6 5
Abbreviations: gPs, general practitioners; hCPs’, health care professionals.
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
1.
24
1.
26
.7
 o
n 
13
-J
an
-2
01
7
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2016:11submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2836
Kayyali et al
medications and patients having multiple co-morbidities 
which make them difficult to manage.
In addition, information provision and enabling patients 
to self-manage and recognize problems in good time were 
reported as challenges.
How well a patient picks up information? Does he remem-
ber it? Should I give him a leaflet? Is that enough? Can the 
patient read? So how do you present the information? How 
long does he remember it and what will the patient do with 
the information?
Self-management of comorbidities was also highlighted 
by HCPs. Diabetologists, for example, described a lack of 
COPD/diabetic patients’ motivation and adherence to pre-
scribed medication:
We have type II who is over 50, 60, 70 and are obese. And 
no matter what information you give them, there is not the 
motivation.
[…] a lot of our younger teenagers with type I diabetes, 
they actually don’t cash in the prescriptions for insulin. So in 
other words they are using about 50% of the insulin that you 
prescribed for them for a six-month period.
Pharmacists’ involvement
HCPs thought that pharmacists should play a role in the care 
of their patients. According to HCPs, pharmacists should 
facilitate medication monitoring, control medication use, 
provide patient counseling and education, and play an advis-
ing and signaling role by identifying any possible interactions 
between medicines.
Discussion
In all five EU countries, our study found that health care 
pathways are fragmented and care is not integrated properly. 
COPD and comorbidities are managed separately with no direct 
communication between different services and care teams. All 
communication goes through the GPs, or the pulmonologists in 
Greece, which creates a challenge for HCPs to monitor patients 
on a day-to-day basis and puts increased pressure on primary 
care. In addition, services fragmentation has been repeatedly 
reported as a barrier to the development of more integrated care 
for patients with complex health care needs.32 Integration within 
and between patient care services and collaboration between 
HCPs are central to high-quality patient care.33 Integrated care 
consists of different concepts and programs intended to achieve 
coordination within and between health care delivery systems, 
with the aim of improving the experience of patients and the 
outcomes of care and enhancing overall efficiency of the health 
systems.34 In fact, several studies have recently reported the 
value of integrated care in terms of reducing hospital admis-
sion and length of stay while improving patients’ adherence to 
treatment and their satisfaction.35–38
There were also country-specific challenges. In England 
and Ireland, there are several services that tackle certain 
issues related to COPD management (eg, adherence and 
smoking), but these are not embedded as part of the care 
pathway. Thus, the pathways shown in Figure 1 illustrate 
the typical services but might be missing key services. These 
missing services only benefit patients on “ad hoc” basis as 
they have not been embedded in the care pathway or are 
missing a defined referral procedure.
Despite the fact that pharmacists can play an important 
role in COPD care delivery, our study found that HCPs are 
not aware of the benefits of such a role. Literature shows 
that pharmacist-led interventions can produce cost-savings, 
provide medicine education, and improve patients’ adherence 
to treatment and health-related QoL leading to a reduction in 
hospitalization and emergency department visits.39–43
Similarly, although the management of COPD is often 
shared between the patients and their carers including family 
and/or friends, no defined role was found for them in the care 
pathway. It is estimated that there were ~125 million carers in 
Europe in 2009, and due to the aging population, this number 
is expected to increase dramatically in the next 10–20 years.44 
Carers could provide assistance with daily self-management 
tasks (such as personal care), coordination and interaction 
with supportive services (such as health appointments), and 
emotional support. Thus, they can be a strong motivator for 
patients to continue to live and engage with the complex 
requirements of self-management.45–50 However, lack of 
professional support is limiting this role, and in fact, this lack 
has been reported as a factor for the stress informal carers 
face while providing care to COPD patients.51
Self-management is challenging in COPD, and it is 
influenced by several factors including physical, psychologi-
cal, social, existential, and providers’ issues.52 In addition, 
despite that variety of effective treatment options exist for 
patients with COPD, long-term adherence to medication is 
required for treatment success.1 Poor patients’ engagement 
and adherence is one of the main factors responsible for 
failure to achieve treatment goals and may also carry a large 
economic burden as a result of increased health care costs, as 
well as increased risk of death and hospital admissions due 
to exacerbations.53,54 Using simplified treatment regimens, 
increasing patient knowledge about self-management, and 
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enhancing provider skills in patient education, communica-
tion, and adherence counseling could help in improving 
patients’ adherence and engagement.55
Finally, as a result of the large demand that COPD is 
putting on all health care systems, conventional manage-
ment is becoming somewhat limited, and more innovative 
approaches, such as telehealth and telemedicine, are required 
to achieve better management.56 Several systematic reviews 
have found that innovative approaches, when compared with 
usual care, show benefits in terms of reduced mortality rates, 
hospital admissions, and accident and emergency department 
visits, enhanced QoL, and improved patient self-care.57–61 
Only England and Ireland currently provide such services 
for COPD patients to enable them to better manage their 
condition and its comorbidities.
In order to optimize current care pathways, services and 
professional integration between care settings is a priority. 
In addition, better communication between health care 
providers, establishing a clear role for informal carers, and 
enhancing patients’ engagement are also important factors 
that help in achieving a better integrated system.
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